Glycopeptide Product Research Articles

Yeast oligosaccharyltransferase: glycosylation of peptide substrates and chemical characterization of the glycopeptide product

Yeast oligosaccharyltransferase: glycosylation of peptide substrates and chemical characterization of the glycopeptide product

Cell‐free N‐glycosylation in Dictyostelium discoideum: Analysis of wild‐type and mutants defective in lipid‐linked oligosaccharide biosynthesis

N-glycosylation was measured in wild-type cell lysates of Dictyostelium discoideum and in two mutant strains that synthesize a truncated lipid-linked oligosaccharide, Man6GlcNAc2 lacking terminal mannose and glucose residues. Endogenous lipid-linked oligosaccharide (LLO) was transferred to octanoyl-Asn-[125I]Tyr-ThrNH2 by membrane fractions. About 50% of the glycopeptide product remained associated with membranes. Taurocholate and saponin promoted and preserved glycosylation, but NP-40 and Triton X-100 did not. Using this artificial assay, the rate and extent of transfer of the truncated lipid-linked oligosaccharide in extracts of the two mutant strains, HL241 and HL243, was reduced 5-10-fold relative to that of wild-type. The low activity found in the mutant strains appears to result from either reduced affinity of the truncated LLO for the transferase or from its improper topological localization in the membrane. When protein N-glycosylation is measured in living cells it is nearly normal in HL241, but it is 3-4-fold decreased in HL243. Although the results of the in vitro and in vivo assays differ, they are not in conflict. Rather, they suggest that the static in vitro assay may be capable of revealing subtleties in the productive positioning of LLO and the oligosaccharyl transferase. The decrease in glycosylation seen in intact HL243 cells may be a consequence of the pleiotropic effects of the primary mutation rather than a direct result of the altered LLO structure. Genetic analysis showed that the mutation in HL241 is recessive, while the mutation in HL243 is dominant and prevents normal development. Thus, the two mutants share a lesion in lipid-linked oligosaccharide biosynthesis and in cell-free glycosylation, but differ in their in vivo glycosylation. Their primary defects are probably different.

Antifreeze glycoprotein in a “southern” population of atlantic tomcod, Microgadus tomcod

1. 1. A Long Island, New York population of the Atlantic tomcod, Microgadus tomcod, initiated antifreeze glycopeptide production in late fall (water temperatures were about 10°C). 2. 2. Significant quantities occurred in midwinter specimens exposed to ice covered marine field conditions and sub-zero temperatures. 3. 3. Increased antifreeze activity over a 3 month period was indicated by an increase in the total freezing point depression from 0.53 to 0.83°C. 4. 4. A reliable estimate of antifreeze activity is the difference between the freezing and melting temperatures of tomcod plasma samples; termed, thermal hysteresis. 5. 5. This thermal hysteresis increased from 0.05°C to approx. 0.5°C in midwinter samples; a value markedly greater than that measured in a comparable New Brunswick tomcod population.

The enzymatic cleavage of rhodopsin by the retinal pigment epithelium. I. Enzyme preparation, properties and kinetics: Characterization of the glycopeptide product

An enzyme system has been detected in the bovine retinal pigmented epithelium (RPE) which carries out the degradation of rhodopsin. The substrate for these studies was bovine rhodopsin labeled by in vitro techniques with [ 3H]-glucosamine or [ 3H]-mannose, the former being the derivative most extensively examined. Labeled rhodopsin was purified by adsorption and affinity chromatography followed by preparative isoelectric focusing. Cell-free preparations from bovine RPE cleaved rhodopsin to a single glycopeptide. The pH optimum for the reaction was about 3·5. The apparent K m for rhodopsin was about 5 μm. Rhodopsin was cleaved about 55% under saturating conditions, the limited extent of reaction due primarily to its partial inactivation for use as a substrate during the course of the reaction. Inhibition by cleavage products was not observed. Among several tissues which were examined, the RPE was the most active in rhodopsin-cleaving activity. Although stable as a crude extract, the activity of the rhodopsin-cleaving enzyme, as well as the bovine serum albumin (BSA)-cleaving enzyme (cathepsin-D) were rapidly lost upon purification by DEAE-Sephacel and pepstatin-Sepharose. Differences in relative specific activity among tissues as well as differential patterns of purification suggest that the rhodopsin-cleaving enzyme and the BSA-cleaving enzyme of the RPE may not be the same. Using N-retinylopsin as a substrate for the rhodopsin-cleaving enzyme, it was shown that the regions of the cleavage products containing vitamin A were not associated with the glycopeptide. Some of the properties of the product were examined. Its response to ion exchange resins, susceptibility to further cleavage by pronase, amino acid analysis, solubility properties, isoelectric point, and binding by concanavalin A (conA)-Sepharose, were consistent with the product being described as an acidic glycopeptide. The glycopeptide was reactive with the antibody prepared against bovine rhodopsin, and retained the full antigenicity of the intact molecule. This enzyme system may be one of the means whereby the RPE participates in maintaining the physiological concentration of rhodopsin which is synthesized in the retinal and catabolized in the RPE.

Carbohydrate structure and cell differentitation: unique properties of fucosyl-glycopeptides isolated from embryonal carcinoma cells.

From embryonal carcinoma cells labeled with fucose, two main classes of glycopeptide products of Pronase digestion can be distinguished by Sephadex G-50 column chromatography: one eluted near the excluded volume and a smaller one. The large fucosyl-glycopeptides are scarcely present in differentiated cells derived from embryonal carcinoma cells (i.e., fibroblastlike cells, myoblasts, and parietal yolk-sac carcinoma). During in vitro differentiation of embryonal carcinoma cells, these large glycopeptides disappear almost completely. The small glycopeptides were analyzed by paper electrophoresis, concanavalin A-Sepharose affinity chromatography, and digestion with an endoglycosidase. The major components of these glycopeptides from embryonal carcinoma cells appear to be different from complex glycopeptides known to occur in adult cells. The glycopeptide pattern of mouse preimplantation embryos resembles that of embryonal carcinoma cells. These results suggest that the carbohydrate profile changes fundamentally during early stages of mammalian development.